Clinical Trials Browser

Phase 1/2 × Neuroendocrine Tumors × Everolimus × Clear all

NCT03629847 2018-08-14

Treatment of Neuroendocrine Tumors (NETs) With Combination of Everolimus and Radiolabeled Somatostatin Analogue

Phase 1/2 Unknown

Metatropic dwarfism, Neuroendocrine Tumors

NCT01175096 2010-08-04

Safety and Tolerability Profile of RAD001 Daily in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor

Phase 1/2 Unknown

Carcinoid Tumor, Neuroendocrine Tumors